ImportRefusal LogoImportRefusal

Viva Pharmaceutical Inc

⚠️ Moderate Risk

FEI: 3002704547 • Richmond, British Columbia • CANADA

FEI

FEI Number

3002704547

📍

Location

Richmond, British Columbia

🇨🇦

Country

CANADA
🏢

Address

13880 Viking Pl, , Richmond, British Columbia, Canada

Moderate Risk

FDA Import Risk Assessment

36.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

10
Total Refusals
10
Unique Violations
12/12/2018
Latest Refusal
1/31/2003
Earliest Refusal

Score Breakdown

Violation Severity
60.5×40%
Refusal Volume
38.6×30%
Recency
0.0×20%
Frequency
6.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

756×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

23003×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

4823×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

29201×

PESTICIDES

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be adulterated because it contains a pesticide chemical, which is in violation of section 402(a)(2)(B). Contains:

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

4711×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

3331×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

22801×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

2601×

FALSE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.

Refusal History

DateProductViolationsDivision
12/12/2018
54FYF99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2300DIETARYLBL
260FALSE
482NUTRIT LBL
75UNAPPROVED
Division of Northern Border Imports (DNBI)
5/5/2017
63RDL99DENTAL CARIES PROPHYLACTIC N.E.C.
2280DIRSEXMPT
333LACKS FIRM
75UNAPPROVED
Division of West Coast Imports (DWCI)
4/27/2017
66VDA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northern Border Imports (DNBI)
4/12/2012
54HBH04FISH OIL (FATS AND LIPID SUBSTANCES)
75UNAPPROVED
Seattle District Office (SEA-DO)
4/12/2012
54HBH04FISH OIL (FATS AND LIPID SUBSTANCES)
75UNAPPROVED
Seattle District Office (SEA-DO)
4/26/2006
54GBL99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C.
2300DIETARYLBL
473LABELING
482NUTRIT LBL
Seattle District Office (SEA-DO)
8/25/2004
54FYR12GINSENG (HERBAL & BOTANICALS, NOT TEAS)
2920PESTICIDES
Seattle District Office (SEA-DO)
1/31/2003
54YBH99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
2300DIETARYLBL
482NUTRIT LBL
Seattle District Office (SEA-DO)
1/31/2003
53UD12SKIN CARE PREPARATIONS, COSMETIC PRODUCTS CONTAINING ANIMAL BY-PRODUCTS (OTHER ANIMAL BY-PRODUCTS)
471CSTIC LBLG
Seattle District Office (SEA-DO)
1/31/2003
54YBA99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
16DIRECTIONS
75UNAPPROVED
Seattle District Office (SEA-DO)

Frequently Asked Questions

What is Viva Pharmaceutical Inc's FDA import refusal history?

Viva Pharmaceutical Inc (FEI: 3002704547) has 10 FDA import refusal record(s) in our database, spanning from 1/31/2003 to 12/12/2018.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Viva Pharmaceutical Inc's FEI number is 3002704547.

What types of violations has Viva Pharmaceutical Inc received?

Viva Pharmaceutical Inc has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Viva Pharmaceutical Inc come from?

All FDA import refusal data for Viva Pharmaceutical Inc is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.